← Back to headlines
GSK Drug Approved in Japan; Tracsis Trading In-Line
A GSK drug has received approval in Japan, while Tracsis reports its trading performance is in line with expectations.
24 Aug, 06:12 — 24 Aug, 07:39
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
morningstarinvesting-com
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
morningstar21h ago
LONDON BRIEFING: GSK drug approved in Japan; Tracsis trading in-line - Morningstar
LONDON BRIEFING: GSK drug approved in Japan; Tracsis trading in-line Morningstar
Read full article →investing-com22h ago
FDA accepts GSK’s Jemperli application for rectal cancer
By Investing.com
Read full article →Coverage Timeline
First report: investing-com · 24 Aug, 06:12|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
